Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HealthBiomedic is a South Korean biotechnology company specializing in microbiome-based diagnostics and personalized healthcare solutions. Founded in 2017, the company leverages high-throughput sequencing technology to provide its flagship "Gut-Check" service, which analyzes the composition of an individual's intestinal microbiota. Based on these insights, HealthBiomedic develops customized probiotic formulations and functional food ingredients tailored to improve specific health outcomes, such as metabolic regulation and immune support. The company's research and development efforts are focused on identifying novel microbial strains with therapeutic potential for conditions like obesity and inflammatory diseases. By integrating diagnostic data with targeted nutritional interventions, HealthBiomedic aims to lead the transition toward precision medicine in the field of gut health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Health Biomedic.